Nuclear accumulation of cyclin D1 following long-term fractionated exposures to low-dose ionizing radiation in normal human diploid cells

Cell Cycle

Volumn 13, Issue 8, 2014, Pages 1248-1255

  Shimura, Tsutomu ^a   Hamada, Nobuyuki ^b   Sasatani, Megumi ^c   Kamiya, Kenji ^c   Kunugita, Naoki ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b CENTRAL RESEARCH INSTITUTE OF ELECTRIC POWER INDUSTRY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

AKT; Cyclin D1; Double strand breaks; Long term exposure; Low dose radiation

Indexed keywords

CYCLIN D1; PROTEIN KINASE B; BUFFER; CYCLIN D; CYCLINE; ONCOPROTEIN;

ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOPLASM; DIPLOIDY; ENZYME INHIBITION; FIBROBLAST; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; LOW ENERGY RADIATION; MICRONUCLEUS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RESPONSE; SIGNAL TRANSDUCTION; THYMOMA; VIRUS ONCOGENE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL NUCLEUS; METABOLISM; S PHASE CELL CYCLE CHECKPOINT;

BUFFERS; CELL NUCLEUS; CELLS, CULTURED; CYCLIN D; DIPLOIDY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; HUMANS; ONCOGENE PROTEIN V-AKT; PROLIFERATING CELL NUCLEAR ANTIGEN; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84899054395     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.28139     Document Type: Article

References (30)

1. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73:1059-65; PMID:8513492; http://dx.doi.org/10.1016/0092-8674(93)90636-5
2. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci U S A 1998; 95:1091-6; PMID:9448290; http://dx.doi.org/10.1073/pnas.95.3.1091
3. Weber JD, Raben DM, Phillips PJ, Baldassare JJ. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 1997; 326:61-8; PMID:9337851
4. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12; PMID:10385618; http://dx.doi.org/10.1101/gad.13.12.1501
5. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006; 25:5220-7; PMID:16936740; http://dx.doi.org/10.1038/sj.onc.1209615
6. DeGregori J. The Rb network. J Cell Sci 2004; 117:3411-3; PMID:15252123; http://dx.doi.org/10.1242/jcs.01189
7. Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, Takai Y, Kobayashi J, Komatsu K, Fukumoto M. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene 2010; 29:4826-37; PMID:20562919; http://dx.doi.org/10.1038/onc.2010.238
8. Shimura T. Acquired radioresistance of cancer and the AKT/GSK3 â /cyclin D1 overexpression cycle. J Radiat Res 2011; 52:539-44; PMID:21881296; http://dx.doi.org/10.1269/jrr.11098
9. Agami R, Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 2000; 102:55-66; PMID:10929713; http://dx.doi.org/10.1016/S0092-8674(00)00010-6
10. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839
11. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74; PMID:17604717; http://dx.doi.org/10.1016/j.cell.2007.06.009
12. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499-511; PMID:9832503; http://dx.doi.org/10.1101/gad.12.22.3499
13. Tan J, Geng L, Yazlovitskaya EM, Hallahan DE. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium. Cancer Res 2006; 66:2320-7; PMID:16489037; http://dx.doi.org/10.1158/0008-5472.CAN-05-2700
14. Tan J, Hallahan DE. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Cancer Res 2003; 63:7663-7; PMID:14633687
15. Shimura T, Ochiai Y, Noma N, Oikawa T, Sano Y, Fukumoto M. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells. Cell Cycle 2013; 12:773-82; PMID:23388457; http://dx.doi.org/10.4161/cc.23719
16. Shimura T, Fukumoto M, Kunugita N. The role of cyclin D1 in response to long-term exposure to ionizing radiation. Cell Cycle 2013; 12:2738-43; PMID:23974042; http://dx.doi.org/10.4161/cc.25746
17. Shimura T, Toyoshima M, Adiga SK, Kunoh T, Nagai H, Shimizu N, Inoue M, Niwa O. Suppression of replication fork progression in low-dose-specific p53-dependent S-phase DNA damage checkpoint. Oncogene 2006; 25:5921-32; PMID:16682953; http://dx.doi.org/10.1038/sj.onc.1209624
18. Shimura T, Torres MJ, Martin MM, Rao VA, Pommier Y, Katsura M, Miyagawa K, Aladjem MI. Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. J Mol Biol 2008; 375:1152-64; PMID:18054789; http://dx.doi.org/10.1016/j.jmb.2007.11. 006
19. Kim JK, Diehl JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 2009; 220:292-6; PMID:19415697; http://dx.doi.org/10.1002/jcp. 21791
20. Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B, Goradia A, Wasik MA, Klein-Szanto AJ, Rustgi AK, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev 2007; 21:2908-22; PMID:18006686; http://dx.doi.org/10.1101/gad.1586007
21. El-Zein R, Vral A, Etzel CJ. Cytokinesis-blocked micronucleus assay and cancer risk assessment. Mutagenesis 2011; 26:101-6; PMID:21164189; http://dx.doi.org/10.1093/mutage/geq071
22. Lassmann M, Hänscheid H, Gassen D, Biko J, Meineke V, Reiners C, Scherthan H. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer. J Nucl Med 2010; 51:1318-25; PMID:20660387; http://dx.doi.org/10.2967/jnumed.109.071357
23. Dulić V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A 1993; 90:11034-8; PMID:8248208; http://dx.doi.org/10.1073/pnas.90.23.11034
24. Lucibello FC, Sewing A, Brüsselbach S, Bürger C, Müller R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 1993; 105:123-33; PMID:8360268
25. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 1995; 217:205-16; PMID:7698220; http://dx.doi.org/10.1006/excr.1995.1080
26. Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 2012; 11:4642-9; PMID:23187803; http://dx.doi.org/10.4161/cc.22937
27. Leontieva OV, Demidenko ZN, Blagosklonny MV. MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death Differ 2013; 20:1241-9; PMID:23852369; http://dx.doi.org/10.1038/cdd.2013.86
28. Shimura T, Kakuda S, Ochiai Y, Kuwahara Y, Takai Y, Fukumoto M. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2011; 80:540-8; PMID:21398050; http://dx.doi.org/10.1016/j.ijrobp. 2010.12.065
29. Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007; 6:24; PMID:17407548; http://dx.doi.org/10.1186/1476-4598-6-24
30. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011; 11:558-72; PMID:21734724; http://dx.doi.org/10.1038/nrc3090